Interplay between age and disease-modifying treatments in influencing infection risk in multiple sclerosis.

Sarah Lena Susanna JacoberGiulio DisantoRosaria SaccoDelania MengGiulia MallucciUrsula CandrianSebastiano SeminiMassimiliano TibertiClaudio Gobbi Chiara Zecca

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2023)

Treatment with MAB and oral DMTs is associated with higher incidence of infections, with a stronger effect in young MS patients. Disability appears the main predictor of severe infections regardless of treatment.

Keyphrases

multiple sclerosis
end stage renal disease
newly diagnosed
ejection fraction
mass spectrometry
risk factors
ms ms
early onset
white matter
patient reported outcomes